cysteine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, G; Fang, J; Feng, L; Guo, Y; Han, J; Jin, Y; Li, J; Li, R; Lian, M; Liu, H; Liu, S; Liu, Y; Ma, H; Ma, Z; Wan, H; Wang, R; Wang, Y; Yue, C; Zhai, J; Zhang, H | 1 |
1 other study(ies) available for cysteine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Amino Acid Transport System X-AG; Amino Acid Transport System y+; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Proliferation; Cysteine; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2017 |